Affiliations: Department of otology and neurotology, Purpan University Hospital, Pierre Paul Riquet Building, Toulouse, France
Correspondence:
[*]
Corresponding author: Alexandra Weckel, Department of otology and neurotology, Purpan Hospital, CHU de Toulouse, 1 place du Dr Baylac, 31059 Toulouse Cedex 9, France. E-mail: weckel.a@chu-toulouse.fr.
Abstract: Menière’s disease (MD) still presents both diagnostic and therapeutic difficulties. Today, this pathology is diagnosed only on clinical criteria. The development of high resolution magnetic resonance imaging of the inner is very promising to improve diagnostic criteria in MD. MD treatment depending on the practitioner and the clinical center, is mainly based on conservative therapies, and if this fails, non-ablative or ablative therapies. MD therefore always exposes clinicians to diagnostic uncertainties, but also to therapeutic difficulties which still lead to destructive treatments, in the absence of targeted, curative treatments, acting on the cause and not on the consequence of the pathology.
